NT-II™ Collagen for Joint Discomfort and Function
In plain words A study of glucosamine in people 20 to 65, run by Hofseth Biocare ASA. It plans to enroll about 120 people at 1 US site.
Who it lists and where
Who the trial lists, as registered
Lists people 20 to 65. Conditions: Activity-Related Knee Discomfort; Joint Discomfort; Functional Joint Pain; Functional Knee Pain; Knee Acute and Chronic Pain.
- Adults aged 20 to 65 years.
- Self-reported, reproducible knee discomfort associated with any knee-loading activities for at least 3 months prior to screening.
- Discomfort must occur in at least one knee during a nominated aggravating activity at least twice per week and subside with rest.
- VAS rating of 30 mm to 75 mm during the past week for the nominated activity.
6 more inclusion criteria and the exclusion criteria are on the listing.
What it tests, as registered
NT-II™ (240 mg); NT-II™ 480 mg; Glucosamine/Chondroitin
Registered summary
The goal of this clinical trial is to learn whether a natural marine supplement called NT-II™ (Salmon Undenatured Type II Collagen) can help lower knee discomfort caused by physical activity in otherwise healthy adults. Many active people experience knee pain when performing daily movements like climbing stairs, walking long distances, or squatting, even if they do not have a medical diagnosis such as arthritis. This discomfort can limit mobility, impact exercise routines, and reduce overall quality of life. The full summary is on the listing.
Where, as registered
1 US site in 1 state.